Andrew Hirsch

Chief Executive Officer at C4 THERAPEUTICS, INC.

Net worth: 597 783 $ as of 31/05/2026

55 year

Health Technology

Consumer Services

Profile

Andrew J.
Hirsch is President, Chief Executive Officer & Director at C4 Therapeutics, Inc. since 2020.
Mr. Hirsch is an Independent Director at Editas Medicine, Inc. since 2017.
Formerly, Mr. Hirsch was CFO & Head-Corporate Development at Agios Pharmaceuticals, Inc. from 2018 to 2020.
Mr. Hirsch was President, CEO, CAO & Director at DNIB Unwind, Inc. in 2016.
Mr. Hirsch was Chief Financial Officer at Avila Therapeutics, Inc. from 2011 to 2012.
Mr. Hirsch was VP-Corporate Strategy, Mergers & Acquisitions at Biogen, Inc. from 2002 to 2011.
Mr. Hirsch completed undergraduate studies at the University of Pennsylvania in 1992.
Mr. Hirsch earned an MBA from Tuck School of Business at Dartmouth in 1997.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
C4 THERAPEUTICS, INC. 0.12%	22/04/2026	135,209 ( 0.12% )	590 863 $	31/05/2026
EDITAS MEDICINE, INC. 0%	17/06/2026	2,000 ( 0% )	6 920 $	31/05/2026

Andrew Hirsch active positions

Companies	Position	Start
EDITAS MEDICINE, INC.	Director/Board Member	30/05/2017
C4 THERAPEUTICS, INC.	Chief Executive Officer	02/10/2020

All active positions of Andrew Hirsch

Former positions of Andrew Hirsch

Companies	Position	End
AGIOS PHARMACEUTICALS, INC.	Director of Finance/CFO	11/09/2020
DNIB UNWIND INC	Chief Executive Officer	24/07/2016
Avila Therapeutics, Inc. Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs	Director of Finance/CFO	31/03/2012
BIOGEN INC.	Corporate Officer/Principal	01/06/2011

See the detail of Andrew Hirsch's experience

Training of Andrew Hirsch

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andrew Hirsch's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Biogen, Inc. Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases	Health Technology
DNIB Unwind, Inc. DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations	Health Technology
Agios Pharmaceuticals, Inc. Agios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutics	Health Technology
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Avila Therapeutics, Inc. Avila Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops covalent drugs	Health Technology
Tuck School of Business at Dartmouth Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Editas Medicine, Inc. Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines	Health Technology
C4 Therapeutics, Inc. C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer	Health Technology